FHIR Release 3 (STU)

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.3.1.22 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group Maturity Level: 1InformativeUse Context: Not Intended for Production use

This is a value set defined by the FHIR project.

Summary

Defining URL:http://hl7.org/fhir/ValueSet/vaccine-code
Name:Vaccine Administered Value Set
Definition:This identifies the vaccine substance administered - CVX codes.
Committee:Public Health and Emergency Response Work Group
OID:2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:


This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17

 

This expansion generated 19 Apr 2017


This value set contains 239 concepts

CodeSystemDisplay
01http://hl7.org/fhir/sid/cvxDTP
02http://hl7.org/fhir/sid/cvxOPV
03http://hl7.org/fhir/sid/cvxMMR
04http://hl7.org/fhir/sid/cvxM/R
05http://hl7.org/fhir/sid/cvxmeasles
06http://hl7.org/fhir/sid/cvxrubella
07http://hl7.org/fhir/sid/cvxmumps
08http://hl7.org/fhir/sid/cvxHep B, adolescent or pediatric
09http://hl7.org/fhir/sid/cvxTd (adult), adsorbed
10http://hl7.org/fhir/sid/cvxIPV
100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7
101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs
102http://hl7.org/fhir/sid/cvxDTaP/DTP-Hib-Hep B
103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate
104http://hl7.org/fhir/sid/cvxHep A-Hep B
105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted
106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens
107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation
108http://hl7.org/fhir/sid/cvxmeningococcal, unspecified formulation
109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation
11http://hl7.org/fhir/sid/cvxpertussis
110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV
111http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal
112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
113http://hl7.org/fhir/sid/cvxTd (adult) preservative free
114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P
115http://hl7.org/fhir/sid/cvxTdap
116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent
117http://hl7.org/fhir/sid/cvxVZIG (IND)
118http://hl7.org/fhir/sid/cvxHPV, bivalent
119http://hl7.org/fhir/sid/cvxrotavirus, monovalent
12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV
121http://hl7.org/fhir/sid/cvxzoster
122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation
123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203
125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal
126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free
127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09
128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations
129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation
13http://hl7.org/fhir/sid/cvxTIG
130http://hl7.org/fhir/sid/cvxDTaP-IPV
131http://hl7.org/fhir/sid/cvxtyphus, historical
132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical
133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13
134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM
135http://hl7.org/fhir/sid/cvxInfluenza, high dose seasonal
136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O
137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
138http://hl7.org/fhir/sid/cvxTd (adult)
139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
14http://hl7.org/fhir/sid/cvxIG, unspecified formulation
140http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable, preservative free
141http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable
142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7
144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free
145http://hl7.org/fhir/sid/cvxRSV-MAb (new)
146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB
147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation
148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP
149http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal, quadrivalent
15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)
150http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent, preservative free
151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
153http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free
154http://hl7.org/fhir/sid/cvxHep A, IG
155http://hl7.org/fhir/sid/cvxinfluenza, recombinant, injectable, preservative free
156http://hl7.org/fhir/sid/cvxRho(D)-IG
157http://hl7.org/fhir/sid/cvxRho(D) -IG IM
158http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent
159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation
16http://hl7.org/fhir/sid/cvxinfluenza, whole
160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013
161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant
163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV
164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified
17http://hl7.org/fhir/sid/cvxHib, unspecified formulation
18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection
19http://hl7.org/fhir/sid/cvxBCG
20http://hl7.org/fhir/sid/cvxDTaP
21http://hl7.org/fhir/sid/cvxvaricella
22http://hl7.org/fhir/sid/cvxDTP-Hib
23http://hl7.org/fhir/sid/cvxplague
24http://hl7.org/fhir/sid/cvxanthrax
25http://hl7.org/fhir/sid/cvxtyphoid, oral
26http://hl7.org/fhir/sid/cvxcholera
27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
28http://hl7.org/fhir/sid/cvxDT (pediatric)
29http://hl7.org/fhir/sid/cvxCMVIG
30http://hl7.org/fhir/sid/cvxHBIG
31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation
32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4
33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23
34http://hl7.org/fhir/sid/cvxRIG
35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
36http://hl7.org/fhir/sid/cvxVZIG
37http://hl7.org/fhir/sid/cvxyellow fever
38http://hl7.org/fhir/sid/cvxrubella/mumps
39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC
40http://hl7.org/fhir/sid/cvxrabies, intradermal injection
41http://hl7.org/fhir/sid/cvxtyphoid, parenteral
42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant
43http://hl7.org/fhir/sid/cvxHep B, adult
44http://hl7.org/fhir/sid/cvxHep B, dialysis
45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation
46http://hl7.org/fhir/sid/cvxHib (PRP-D)
47http://hl7.org/fhir/sid/cvxHib (HbOC)
48http://hl7.org/fhir/sid/cvxHib (PRP-T)
49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)
50http://hl7.org/fhir/sid/cvxDTaP-Hib
51http://hl7.org/fhir/sid/cvxHib-Hep B
52http://hl7.org/fhir/sid/cvxHep A, adult
53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)
54http://hl7.org/fhir/sid/cvxadenovirus, type 4
55http://hl7.org/fhir/sid/cvxadenovirus, type 7
56http://hl7.org/fhir/sid/cvxdengue fever
57http://hl7.org/fhir/sid/cvxhantavirus
58http://hl7.org/fhir/sid/cvxHep C
59http://hl7.org/fhir/sid/cvxHep E
60http://hl7.org/fhir/sid/cvxherpes simplex 2
61http://hl7.org/fhir/sid/cvxHIV
62http://hl7.org/fhir/sid/cvxHPV, quadrivalent
63http://hl7.org/fhir/sid/cvxJunin virus
64http://hl7.org/fhir/sid/cvxleishmaniasis
65http://hl7.org/fhir/sid/cvxleprosy
66http://hl7.org/fhir/sid/cvxLyme disease
67http://hl7.org/fhir/sid/cvxmalaria
68http://hl7.org/fhir/sid/cvxmelanoma
69http://hl7.org/fhir/sid/cvxparainfluenza-3
70http://hl7.org/fhir/sid/cvxQ fever
71http://hl7.org/fhir/sid/cvxRSV-IGIV
72http://hl7.org/fhir/sid/cvxrheumatic fever
73http://hl7.org/fhir/sid/cvxRift Valley fever
74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent
75http://hl7.org/fhir/sid/cvxvaccinia (smallpox)
76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate
77http://hl7.org/fhir/sid/cvxtick-borne encephalitis
78http://hl7.org/fhir/sid/cvxtularemia vaccine
79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
80http://hl7.org/fhir/sid/cvxVEE, live
801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
81http://hl7.org/fhir/sid/cvxVEE, inactivated
82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation
83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose
84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose
85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation
86http://hl7.org/fhir/sid/cvxIG
87http://hl7.org/fhir/sid/cvxIGIV
88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation
89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation
90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation
91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation
92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation
93http://hl7.org/fhir/sid/cvxRSV-MAb
94http://hl7.org/fhir/sid/cvxMMRV
95http://hl7.org/fhir/sid/cvxTST-OT tine test
96http://hl7.org/fhir/sid/cvxTST-PPD intradermal
97http://hl7.org/fhir/sid/cvxTST-PPD tine test
98http://hl7.org/fhir/sid/cvxTST, unspecified formulation
99http://hl7.org/fhir/sid/cvxRESERVED - do not use
998http://hl7.org/fhir/sid/cvxno vaccine administered
999http://hl7.org/fhir/sid/cvxunknown
AGRPALurn:oid:1.2.36.1.2001.1005.17Agrippal
AVAXMurn:oid:1.2.36.1.2001.1005.17Avaxim
BCGurn:oid:1.2.36.1.2001.1005.17BCG
CDTurn:oid:1.2.36.1.2001.1005.17CDT
CMXurn:oid:1.2.36.1.2001.1005.17COMVAX
DTPurn:oid:1.2.36.1.2001.1005.17Triple Antigen
DTPAurn:oid:1.2.36.1.2001.1005.17DTPa
ENGPurn:oid:1.2.36.1.2001.1005.17Engerix B
FLRIXurn:oid:1.2.36.1.2001.1005.17Fluarix
FLUVAXurn:oid:1.2.36.1.2001.1005.17Fluvax
FLVRNurn:oid:1.2.36.1.2001.1005.17Fluvirin
FVXJNRurn:oid:1.2.36.1.2001.1005.17Fluvax Junior
GNDIPurn:oid:1.2.36.1.2001.1005.17Diphtheria
GNFLUurn:oid:1.2.36.1.2001.1005.17Influenza
GNHEPurn:oid:1.2.36.1.2001.1005.17Hepatitis B
GNHIBurn:oid:1.2.36.1.2001.1005.17HIB
GNHPAurn:oid:1.2.36.1.2001.1005.17Hepatitis A
GNJENurn:oid:1.2.36.1.2001.1005.17Japanese Encephalitis
GNMEAurn:oid:1.2.36.1.2001.1005.17Measles
GNMENurn:oid:1.2.36.1.2001.1005.17Meningococcal C
GNMUMurn:oid:1.2.36.1.2001.1005.17Mumps
GNPNEurn:oid:1.2.36.1.2001.1005.17Pneumococcal
GNPOLurn:oid:1.2.36.1.2001.1005.17Polio
GNROXurn:oid:1.2.36.1.2001.1005.17Rotavirus
GNRUBurn:oid:1.2.36.1.2001.1005.17Rubella
GNTETurn:oid:1.2.36.1.2001.1005.17Tetanus
GNVARurn:oid:1.2.36.1.2001.1005.17Varicella
HATWNJurn:oid:1.2.36.1.2001.1005.17Twinrix Junior
HAVAQurn:oid:1.2.36.1.2001.1005.17Vaqta Paed/Adol
HAVJurn:oid:1.2.36.1.2001.1005.17Havrix Junior
HBOCurn:oid:1.2.36.1.2001.1005.17HibTITER
HBVurn:oid:1.2.36.1.2001.1005.17HBV
HBVPurn:oid:1.2.36.1.2001.1005.17HBVAX II
HBXurn:oid:1.2.36.1.2001.1005.17Hiberix
IFHXurn:oid:1.2.36.1.2001.1005.17Infanrix Hexa
IFIPurn:oid:1.2.36.1.2001.1005.17Infanrix-IPV
IFPAurn:oid:1.2.36.1.2001.1005.17Infanrix Penta
IFXurn:oid:1.2.36.1.2001.1005.17Infanrix
IFXBurn:oid:1.2.36.1.2001.1005.17InfanrixHepB
INFLUVurn:oid:1.2.36.1.2001.1005.17Influvac
IPVurn:oid:1.2.36.1.2001.1005.17IPOL
JEVAXurn:oid:1.2.36.1.2001.1005.17JE-VAX
MENJUGurn:oid:1.2.36.1.2001.1005.17Menjugate
MENTECurn:oid:1.2.36.1.2001.1005.17Meningitec
MENUMEurn:oid:1.2.36.1.2001.1005.17Menomune
MENVAXurn:oid:1.2.36.1.2001.1005.17Mencevax ACWY
MMRurn:oid:1.2.36.1.2001.1005.17MMR
MMRCSLurn:oid:1.2.36.1.2001.1005.17MMR II
MMRSKBurn:oid:1.2.36.1.2001.1005.17Priorix
MNTRXurn:oid:1.2.36.1.2001.1005.17Menitorix
NEISVCurn:oid:1.2.36.1.2001.1005.17NeisVac-C
OPVurn:oid:1.2.36.1.2001.1005.17Polio
Purn:oid:1.2.36.1.2001.1005.17Pertussis
PANVAXurn:oid:1.2.36.1.2001.1005.17Panvax
PDCLurn:oid:1.2.36.1.2001.1005.17Pediacel
PLCLurn:oid:1.2.36.1.2001.1005.17Poliacel
PNEUMOurn:oid:1.2.36.1.2001.1005.17Pneumovax
PRPDurn:oid:1.2.36.1.2001.1005.17ProHIBit
PROQADurn:oid:1.2.36.1.2001.1005.17ProQuad
PRPOMPurn:oid:1.2.36.1.2001.1005.17PedvaxHIB
PRPTurn:oid:1.2.36.1.2001.1005.17ActHIB
PRVNRurn:oid:1.2.36.1.2001.1005.17Prevenar 7
PRVTHurn:oid:1.2.36.1.2001.1005.17Prevenar 13
PRXTEXurn:oid:1.2.36.1.2001.1005.17Priorix-Tetra
QDCLurn:oid:1.2.36.1.2001.1005.17Quadracel
ROTRIXurn:oid:1.2.36.1.2001.1005.17Rotarix
ROTTEQurn:oid:1.2.36.1.2001.1005.17Rotateq
SYNFLXurn:oid:1.2.36.1.2001.1005.17Synflorix
TCLurn:oid:1.2.36.1.2001.1005.17Tripacel
VAXGRPurn:oid:1.2.36.1.2001.1005.17Vaxigrip
VGRJNRurn:oid:1.2.36.1.2001.1005.17Vaxigrip Junior
VLRIXurn:oid:1.2.36.1.2001.1005.17Varilrix
VRVAXurn:oid:1.2.36.1.2001.1005.17Varivax

 

See the full registry of value sets defined as part of FHIR.


Explanation of the columns that may appear on this page:

LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code